Safety first
What to know before starting online GLP-1 treatment
GLP-1 weight-loss medications like semaglutide and tirzepatide are prescription-only treatmentswith real effects on your body. Done right — with a proper medical intake, clinician oversight and slow titration — they're safe for most eligible adults. Here's what a responsible program looks like.
Safety resources
Common side effects
Nausea, vomiting, diarrhea, constipation, and reflux are the most common — usually worst early and easing with slow dose titration.
Who shouldn't take it
A personal or family history of medullary thyroid carcinoma or MEN2, and pregnancy or planning pregnancy, generally rule out GLP-1 therapy.
Pancreatitis history
A prior history of pancreatitis warrants caution. Tell your clinician so they can weigh risks before prescribing.
Slow titration matters
Doses are stepped up gradually. Rushing the schedule drives the worst nausea — a good clinic titrates, it doesn't max you out.
Compounded vs brand-name
Compounded semaglutide and tirzepatide exist via telehealth. Understand sourcing, labeling, and the trade-offs versus brand-name products.
Prescription-only medication
Semaglutide and tirzepatide require a prescription and licensed clinician oversight — including an eligibility and medical intake review.
Essential safety checklist
Verify the clinic uses licensed clinicians
A legitimate online clinic requires a real medical intake and has a licensed clinician review your eligibility — never a questionnaire-only auto-approval.
Insist on proper intake and follow-up
If a provider skips your medical history, current meds, or contraindication screening, walk away. Oversight and titration are what keep GLP-1 treatment safe.
Report side effects to FDA MedWatch
Serious adverse events can be reported at fda.gov/medwatch — and tell your prescriber immediately.
This page is educational information, not medical advice. Always consult a licensed clinician before starting, changing, or stopping treatment.